Company’s first-ever share buyback program underscores management and the Board’s confidence in UMG’s strategy and long-term growth HILVERSUM, The Netherlands,…
SHANGHAI, March 30, 2026 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization…
Co-development of physical AI services integrating AI avatars and autonomous robotsExploration of applications across retail, finance, manufacturing and public sectors…